• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Oct30
Traws Pharma Extends Contracts with ChemDiv and Expert Systems to Support Ratutrelvir Clinical Development
16:00
Oct22
Traws Pharma Initiates Phase 2 Clinical Trial for Ratutrelvir
22:40
Oct14
Traws Pharma Initiates Phase II Clinical Trials for Ratutrelvir
11:03
Aug14
Traws Pharma released FY2025 Q2 earnings on August 14 During-Market EST, actual revenue USD 2.733 M (forecast USD 60 K), actual EPS USD -0.1571 (forecast USD -8.75)
20:00
Traws Pharma released FY2025 Semi-Annual Earnings on August 14 During-Market (EST), Actual Revenue: USD 2.79 M, Actual EPS: USD 1.95
20:00
Aug7
Traws Pharma to Release FY2025 Q2 Earnings on August 14 During-Market (EST), Forecast Revenue USD 60K, EPS USD -8.75
00:07

Schedules & Filings

Schedules
Filings
Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 2.733 M, Net Income -625 K, EPS -0.1099

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 57 K, Net Income 15.08 M, EPS 2.0899

Mar31
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 56 K, Net Income 81.93 M, EPS 26.6048

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
CDTX
217.685
+105.38%
+111.695
CYPH
2.830
+60.80%
+1.069
CYCU
6.108
+46.11%
+1.930
IVVD
2.415
+36.44%
+0.645
BCG
1.935
+35.79%
+0.510
TRAW
2.370
+33.90%
+0.600
BCAB
0.8500
+28.85%
+0.190
AGCC
6.970
+28.84%
+1.560
TOI
3.935
+27.76%
+0.860
PGEN
4.925
+27.59%
+1.055
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy